Atlas Trials

Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)

Clinical trial NCT06088134 · RECRUITING

Trial details

NCT number
NCT06088134
Sponsor
Mingzhao Xiao
Status
RECRUITING
Study type
OBSERVATIONAL
Clear Cell Renal Cell CarcinomaPrognostic Cancer ModelRecurrent Renal Cell Cancer
Start date
2022-09-01
Primary completion
2025-06-01
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.